Your browser doesn't support javascript.
loading
Phase I clinical trial of KML001 monotherapy in patients with advanced solid tumors.
Kim, Seokuee; Kim, Sujong; Park, Young Suk; Park, Joon Oh; Lim, Ho Yeong; Ahn, Jin Seok; Lee, Jeeyun; Sun, Jong Mu; Kang, Won Ki; Han, RaeO; Kim, Jungryul; Ahn, Myung-Ju.
Affiliation
  • Kim S; Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center , Seoul, Republic of Korea.
  • Kim S; Pharmaceutical Division, Komipharm International Co., Ltd ., Siheung, Republic of Korea.
  • Park YS; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Republic of Korea.
  • Park JO; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Republic of Korea.
  • Lim HY; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Republic of Korea.
  • Ahn JS; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Republic of Korea.
  • Lee J; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Republic of Korea.
  • Sun JM; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Republic of Korea.
  • Kang WK; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Republic of Korea.
  • Han R; Pharmaceutical Division, Komipharm International Co., Ltd ., Siheung, Republic of Korea.
  • Kim J; Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center , Seoul, Republic of Korea.
  • Ahn MJ; Department of Clinical Research Design & Evaluation, SAIHST, Sungkyunkwan University , Seoul, Republic of Korea.
Expert Opin Investig Drugs ; 29(9): 1059-1067, 2020 Sep.
Article in En | MEDLINE | ID: mdl-32735765
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium Compounds / Arsenites / Neoplasms / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium Compounds / Arsenites / Neoplasms / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article